arrow
D

David Sebag-Montefiore

University of Leeds
H指数:58
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Personalising radiotherapy dose in anal cancer (PLATO) Platform: 6-month patient reported outcomes across ACT3, ACT4 and ACT5 trials

个人化肛管癌放射治疗剂量(PLATO)平台:ACT3、ACT4和ACT5试验中的6个月患者报告结局

2026-07-010
OA
AI-powered immune profiling from histopathology slides for chemo-radiotherapy outcome prediction in rectal cancer: a study using clinical trial and real-world cohorts

基于AI的免疫表型分析用于预测直肠癌放化疗效果:一项基于临床试验和真实世界队列的研究

2025-11-170
OAAI
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trial

个性化肛门癌放疗剂量 (PLATO): 多中心综合平台试验方案

2025-11-090
OA
Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial

肿瘤浸润淋巴细胞、肿瘤细胞密度及新辅助短程放疗的反应在直肠癌中:一项来自MRC CR07临床试验的转化子研究

2025-09-230
OAAI
Predicting acute diarrhoea in rectal cancer chemoradiotherapy: Secondary analysis of the phase III ARISTOTLE trial

预测直肠癌化疗放疗中的急性腹泻:ARISTOTLE III期试验的二次分析

2025-07-050
PRE
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
2024-09-010
PRE
Identi fi cation and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune in fi ltrate and TGF P as key predictors
2024-08-011
OAAI
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
2024-04-097
OAAI
Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision
2022-12-0115
OA